Press Releases

Washington, DC – The Global CEO Initiative on Alzheimer’s Disease (CEOi) today announced that the Roche Group, a leading global healthcare company, will join the CEOi as part of its ongoing effort to advance innovations in research and drug development to stop Alzheimer’s by 2025.  Roche is at the forefront of Alzheimer’s research and drug development, and is a recognized leader in innovation and developing differentiated medicines.

Washington, DC – African Americans are two to three times more likely to develop Alzheimer’s disease than white Americans, yet they are less likely to be diagnosed.  While Alzheimer’s is the sixth leading cause of death in the United States, it is the fourth leading cause of death for older African Americans. 

Alzheimer’s is the only disease in the top ten that currently has no cure, treatment, or prevention.

Washington, DC – A key Senate committee included $100 million in additional funding for Alzheimer’s research at the National Institutes of Health (NIH), acting just days before today’s briefing on new mortality data that suggests more than a half-million U.S. deaths every year are attributable to Alzheimer’s disease, making it the third leading cause of death.

Washington, DC – The Global CEO Initiative on Alzheimer’s Disease (CEOi), Sage Bionetworks and DREAM Project, today launched the Alzheimer’s Disease Big Data DREAM Challenge #1 in an effort to advance diagnostic innovation and identify new Alzheimer’s disease biomarkers through the use of open source data. 

Washington, DC – The World Dementia Council, meeting for the first time in London, England on Wednesday, agreed to priorities for the upcoming year and to mobilizing a worldwide effort to find a cure for Alzheimer’s and dementia.  Supported by the UK Government, and an outgrowth of the 2013 G8 Dementia Summit, the World Dementia Council was created to champion innovation in dementia across diagnosis, treatment, and care and to unlock far greater amounts of investment.  The Council will support Dr. Dennis Gillings, the World Dementia Envoy.

Pages

^ Back to Top